Results 201 to 210 of about 19,263 (243)

Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study [PDF]

, 2019
Ahmadi, T, Arkenau, HT, Boccadoro, M, Cavenagh, J, Chen, D, Chiu, C, de Boer, C, Gay, F, Krejcik, J, Laubach, JP, Minnema, MC, Moreau, P, Perrot, A, Plesner, T, Richardson, PG, Schecter, JM   +15 more
core  

Safety and Outcomes of Rapid Drug Desensitization to Various Biologic Agents: A Multidisciplinary Experience. [PDF]

J Asthma Allergy
Kirdok K, Ertuna E, Ates U, Galata Z, Senturk MIT, Kural RF, Ay E, Aslan E, Canbaz TD, Gumusburun R, Mete Gokmen EN, Sin AZ, Tunakan Dalgic C.   +12 more
europepmc   +1 more source

The addition of CD38 monoclonal antibody to triplet regimens improves survival in newly diagnosed multiple myeloma with high-risk cytogenetics: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Immunol
Hu B, Fang D, Jiang L, Li T, Chen K, Cao J, Wang J.   +6 more
europepmc   +1 more source

Hematologic response and kidney outcomes of monoclonal gammopathy of renal significance excluding AL amyloidosis: a report of six cases. [PDF]

BMC Nephrol
Nobayashi H, Haruhara K, Nakamura T, Shiina Y, Katsuma A, Okabe M, Suzuki K, Tsuboi N, Yano S, Yokoo T.   +9 more
europepmc   +1 more source

Combined mesenchymal stem cells and telitacicept therapy for Evans syndrome refractory to various immunosuppressive: a case report. [PDF]

Res Pract Thromb Haemost
Liu W, Dong H, Xue F, Pei X, Han Z, Yang R, Zhang L.   +6 more
europepmc   +1 more source

Addition of daratumumab to standard triplet regimens achieved better survival in newly diagnosed multiple myeloma: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Front Oncol
Hu B, Wang J, Fang D, Jiang L, Li T, Cao J.   +5 more
europepmc   +1 more source

A SUCCESSFUL CASE OF PRIMARY PLASMA CELL LEUKEMIA TREATED WITH DARATUMUMAB-BASED THERAPY FOLLOWED BY AUTOLOGOUS BONE MARROW TRANSPLANTATION

Afërdita Ukimeraj, Viola Çavolli, Suzana Krasniqi   +2 more
openalex   +1 more source

Ixazomib-Lenalidomide-Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: A Hungarian Real-World Analysis. [PDF]

J Clin Med
Sánta H, Regáli L, Váróczy L, Szita V, Wiedemann Á, Varju L, Rejtő L, Bartha NS, Máté D, Masszi A, Plander M, Kosztolányi S, Hussain A, Pettendi P, Istenes I, Szomor Á, Reményi P, Masszi T, Varga G, Mikala G.   +19 more
europepmc   +1 more source

Toward a cure for multiple myeloma within a decade. [PDF]

Blood Cancer J
Mohty M, Malard F, Facon T, Harousseau JL.   +3 more
europepmc   +1 more source

A rabbit anti-human CD38 antibody for eliminating daratumumab and isatuximab interference in immunohematology testing. [PDF]

Front Immunol
Zhang L, Zhang Y, Qi J, Su X, Zuo Q, Yan F, Cui Y, Li N, Dong Y, Xu H.   +9 more
europepmc   +1 more source